CRISPR Therapeutics AG (CRSP): A Bull Case Theory

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on Two Natural Cap’s Substack. In this article, we will summarize the bulls’ thesis on CRSP. CRISPR Therapeutics AG (CRSP)'s share was trading at $41.52 as of 11^th June. CRSP’s trailing and forward P/E were 22.55 and 23.36 respectively according to Yahoo Finance.

[caption id="attachment_1209732" align="aligncenter" width="768"] A scientist peering into a microscope, researching the next gene therapy breakthrough.[/caption]

CRISPR has re-entered the spotlight thanks to a groundbreaking case where the technology...